T. Rowe Price Investment Management, Inc., a registered investment adviser, initiated a new position in Becton, Dickinson and Company (NYSE:BDX) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 14,378,219 shares of the Healthcare company, valued at approximately $2.8B as of the filing date.
Becton, Dickinson and Company's stock currently trades at $185.05 with a market capitalization of $57.4B.
